Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

361 Tue, 8/1/2017, 12:30 PM - 1:50 PM CC-Ballroom II
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Qi Jiang, Amgen Inc.
TL09: Benefit-Risk Analysis in Medical Development Shuai Yuan, Merck
TL10: Dose Finding in Oncology Trials: a Discussion on Challenges and Current Methods Zhao Yang, Amgen, Inc.
TL11: FDA/Industry-Wide Recommended Analyzes and Displays: a Vision Within Reach Sheryl Treichel, Amgen
TL12: Integrating Data Science and Big Data Concepts and Machine Learning in Drug Safety Melvin Munsaka, Safety Statistics and Observational Res Analytics, Takeda
TL13: Personalized Endpoints Marian Strazzeri, US Food and Drug Administration
Copyright © American Statistical Association